Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine (REHSI)
Reducing Elevated Heart Rate in Patients With Severe Sepsis by by the Funny Channel Current (If) Inhibitor Ivabradine
Sponsor: Peking Union Medical College Hospital
This NA trial investigates Sepsis, Severe and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Jan 2021 [monthly]
Not Yet Recruiting NA
▶ Show 3 earlier versions
-
Jul 2018 — Aug 2018 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.